Penile Filler Before and After Erect: The True Benchmark Explained
Introduction: The Question Every Man Actually Wants Answered
Nearly every before-and-after gallery in the penile enhancement industry shares the same blind spot: the photographs show only the flaccid state. Yet the flaccid state is not the condition that matters most to a man or his partner. The erect state is. It is the context in which enhancement is actually experienced, and it is the only benchmark that reveals whether a procedure truly worked.
For the successful professional who has quietly researched this topic and weighed options carefully before making any decision, this omission is frustrating. He wants a definitive, clinically grounded answer to one question: does penile filler produce natural, proportional results during erection?
This article answers that question directly. It explains why the erect state is the only meaningful benchmark for evaluating filler outcomes, and why anatomical precision combined with high procedure volume (the standard practiced at Stoller Medical Group, with over 15,000 procedures performed) consistently produces natural, proportional erect-state results.
The research gap is real. A 2025 study in the World Journal of Men’s Health explicitly noted that “the erect state of the penis was not assessed” as a limitation, acknowledging that erect-state measurement would provide more comprehensive information. Even peer-reviewed literature rarely documents the state that matters most. This piece was written to close that gap with the depth and respect the subject deserves.
Why the Flaccid State Is the Wrong Benchmark
Flaccid appearance is notoriously variable. It fluctuates with temperature, stress, hydration, and arousal level. A man can measure himself twice in a single day and see meaningfully different results. This variability makes the flaccid state an unreliable measure of any procedure’s success.
The erect state, by contrast, is anatomically consistent. It represents the fixed condition during sexual activity, the exact context in which enhancement is meant to matter. Evaluating filler results in the flaccid state is like evaluating an athlete during warm-up rather than competition.
The psychological evidence reinforces this. A 2025 NIH-indexed study of 200 men found that men with small penis anxiety experienced significant reductions in anxiety and depression scores when counseled in the erect state rather than the flaccid state. The erect-state outcome is not just the physically relevant benchmark; it is the psychologically meaningful one.
This matters at scale. Approximately 12% of the male population perceives their penis as small, and an estimated 3.6% ultimately seek enhancement. For this large group, the primary concern has always been erect-state appearance.
Flaccid gains are real and documented. A 2025 single-center study of 324 patients reported a mean flaccid girth increase of 2.5 cm. Those gains are best understood as a secondary benefit, however. If the erect state is the true benchmark, the next question is whether filler actually produces natural, proportional results during erection, and why.
The Biomechanics of Erection and Where Filler Is Placed
Understanding the answer requires a brief look at anatomy. The tunica albuginea is the fibrous sheath surrounding the erectile chambers. It expands during erection and determines erect dimensions. Outside this structure lies the sub-Dartos and Buck’s fascial plane.
This distinction is the entire mechanism. Filler is placed in the sub-Dartos/Buck’s fascial plane, outside the tunica albuginea. Because it sits outside the structure that governs erection, it expands proportionally with the penis rather than creating rigidity or distortion. As one urologist explained, hyaluronic acid placed between Buck’s fascia and the dartos layer “integrates mechanically rather than chemically, adding volume by attracting water and creating structural expansion” that accommodates the natural biomechanics of erection.
This also sets a critical expectation. Because filler is placed outside the tunica albuginea, it increases girth in both the flaccid and erect states but does not increase erect length. Length is determined by the tunica albuginea, which filler does not affect. Informed decision-making depends on understanding this clearly.
Placement depth is the primary determinant of quality. Filler injected too superficially (into subcutaneous tissue rather than the correct fascial plane) migrates, creates nodularity, and produces poor erect-state appearance. Anatomical knowledge, not the product itself, drives the aesthetic result.
This connects directly to procedure volume. At 15,000-plus procedures, sub-Dartos/Buck’s fascial plane placement is not theoretical for Stoller Medical Group. It is a practiced, repeatable technique refined across thousands of cases.
What the Clinical Evidence Actually Shows About Erect-State Results
The most valuable published evidence comes from a 2025 Cureus case report, one of the few to explicitly document erect-state outcomes. It recorded a 0.63-inch flaccid girth gain that “carried forward to erect girth gain (5.93 inches),” with the clinician rating the result “Much Improved” on the Global Aesthetic Improvement Scale at six months, with a natural feel and no complications.
Larger datasets confirm efficacy while illustrating the research gap. The 2025 single-center Journal of Sexual Medicine study of 324 patients reported 89% satisfaction and a mean 2.5 cm flaccid girth increase, yet even this substantial dataset did not formally measure erect girth. A 2024 study of 155 men found an average girth increase of 1.8 cm overall, rising to 2.952 cm among men who received four or more treatments, directly supporting a staged approach.
On safety, retrospective data on nearly 500 patients presented at the 2024 SMSNA Annual Meeting reported no cases of erectile dysfunction or penile sensation loss with properly performed HA procedures. The SMSNA 2024 position statement acknowledged that “limited data suggest benefit and acceptable safety profile using temporary fillers,” representing mainstream medical validation.
The research gap is itself a differentiator. Academic studies are constrained by IRB protocols and measurement standardization challenges, and a high-volume clinical practice accumulates real-world erect-state outcome data that published literature currently lacks.
The Grower vs. Shower Distinction: Why It Changes Before-and-After Expectations
The terms are straightforward. A “shower” has a flaccid size close to his erect size. A “grower” has a significantly smaller flaccid size that expands substantially during erection.
For growers, filler provides a structural foundation that prevents full retraction, creating a more consistent flaccid presence. The erect-state gain remains the true measure of success, however, and that gain is proportional regardless of starting flaccid size. Notably, growers often underestimate their own erect-state gains because they are accustomed to judging themselves in the flaccid state, which is precisely why erect-state documentation matters most for this group.
For showers, the flaccid gain is more immediately visible, and the erect-state result is a proportional continuation of that gain.
This is why the consultation process at Stoller Medical Group begins by understanding whether a patient is a grower or a shower. That understanding informs treatment planning and realistic goal-setting. In both cases, sub-Dartos/Buck’s fascial plane placement ensures the filler accommodates the erectile mechanism naturally.
Proportionality: The Aesthetic Standard That Separates Natural Results from Obvious Ones
Proportionality is the key aesthetic benchmark for erect-state results. Natural penile anatomy maintains specific shaft-to-glans proportions that must be preserved for a result to look natural during erection.
The problem arises when shaft girth increases without proportional glans enhancement. The erect result then looks unnatural, a common oversight in single-focus treatment plans. Stoller Medical Group addresses this by offering glans enlargement simultaneously with shaft treatment, preserving the shaft-to-glans ratio that defines natural erect-state aesthetics.
Clinical data confirms that multi-zone treatment is achievable. An Oxford Academic Aesthetic Surgery Journal study reported mean girth enlargement of 1.7 cm at midshaft and 1.5 cm at the glans. Proportional treatment across zones is not aspirational; it is documented.
Proportionality is also why conservative, staged treatment outperforms aggressive single-session volume. Incremental gains allow the provider to assess and adjust proportions at each stage. This is an engineering principle, not a preference. The staged philosophy is designed to produce erect-state results that are proportional by design, not by chance.
Why Staged Treatment Produces Superior Erect-State Results
Staged treatment means multiple sessions spaced two or more weeks apart rather than a single high-volume injection. The clinical rationale is sound: spacing prevents lymphatic overload, reduces granuloma risk, and allows progressive tissue expansion. A 2025 NIH-indexed case series documenting PLA granuloma complications serves as a cautionary contrast to careful, staged HA protocols.
The methodology is well documented. U.S. Patent No. 10,105,228 describes a staged HA injection protocol of 2 to 4 mL per session, spaced to protect lymphatics, with experimental data on 121 patients showing zero complications and a mean filler volume of 10.7 mL.
Staged treatment connects directly to erect-state aesthetics. Progressive volume addition allows the provider to assess erect-state proportionality at each stage and adjust accordingly, something a single session cannot do. The 2024 study of 155 men supports the cumulative benefit: four or more treatments produced an average 2.952 cm gain, nearly double the single-session average. For Stoller Medical Group, the staged philosophy is a clinically engineered protocol, not a marketing preference.
The Timeline of Erect-State Improvement: What to Expect and When
HA filler integrates with the body’s water molecules over 2 to 4 weeks, softening and becoming more natural-feeling. This means the erect-state appearance continues to improve in the weeks following treatment.
- Immediate: Visible enhancement is present right away, though some swelling and firmness are normal in the first 7 to 10 days.
- Recovery: Patients typically return to daily activities immediately or the next day. Sexual activity resumes within 7 to 10 days, a 10-day recovery compared to 40-plus days for permanent filler alternatives.
- 2 to 4 weeks: Filler softens and integrates. Erect-state appearance becomes more natural and proportional as tissue accommodation occurs.
- 6 to 8 weeks: The stable, natural erect-state outcome (comparable to the six-month result documented in the 2025 Cureus case report) is typically visible by this point.
- Follow-up: Usually scheduled 2 to 3 months after the initial treatment, allowing assessment of erect-state results and planning of any staged additions.
The key expectation: the erect-state result at 48 hours is not the final result. The erect-state result at 6 to 8 weeks is the true benchmark.
Safety, Reversibility, and What Happens If the Erect-State Result Needs Adjustment
HA fillers are fully reversible with hyaluronidase. This is a decisive safety differentiator that directly addresses erect-state concerns: if the result does not meet expectations, it can be adjusted or dissolved.
The safety record is strong. Retrospective data on nearly 500 patients showed no reports of erectile dysfunction or penile sensation loss with properly performed HA procedures. The SMSNA 2024 position statement and the AUA’s evolving acceptance both reflect growing mainstream validation.
Stoller Medical Group uses Belefil®, an HA-based, biocompatible, reversible filler with transparent safety data, not an experimental compound. While 80 to 90% permanent improvement in girth is achievable, the reversibility option always remains available. This is not an irreversible commitment.
Complication risk stems from improper technique, as the 2025 PLA granuloma case series illustrates. Sub-Dartos/Buck’s fascial plane placement by an experienced provider is the primary risk-mitigation factor. If the erect-state result at 6 to 8 weeks does not meet expectations, a clinical pathway exists to adjust it.
Stoller Medical Group: Why 15,000-Plus Procedures Translates to Predictable Erect-State Outcomes
Procedure volume is the specific clinical reason erect-state results are consistently natural and proportional. At 15,000-plus procedures, sub-Dartos/Buck’s fascial plane placement is a practiced, repeatable technique. The provider has encountered the full range of anatomical variation and knows how to adapt placement for consistent outcomes.
Dr. Roy B. Stoller is a board-certified physician with 25-plus years in aesthetic and restorative medicine and five years dedicated specifically to non-surgical male enhancement. He is a recognized expert in dermal fillers for penile enhancement.
The five-location footprint across Manhattan, Long Island, Albany, Pennsylvania, and Minnesota reflects a scaled, systematized practice, not a single-provider boutique where outcomes depend on one person’s availability. The staged treatment philosophy is a clinically engineered protocol designed to keep erect-state results proportional at every stage. The free consultation is the entry point, where erect-state goals are discussed, anatomy is assessed, and a staged plan is designed around specific proportionality targets.
Investment and Treatment Planning: What to Expect Financially
Pricing starts at $7,500 and increases depending on desired results and the number of syringes required. Treatment is priced by syringe. Most men start with a minimum of 10 syringes, and the average first procedure involves approximately 15 syringes.
This structure fits the staged philosophy. The initial procedure establishes the foundation, while follow-up sessions add volume incrementally based on the erect-state assessment at the 2-to-3-month follow-up. Patients are not committing to a single high-volume session; they are investing in a progressive, assessable process where erect-state results guide each stage.
The reversibility of HA filler provides a clinical safety net, so the investment is not irreversible if expectations are not met. The free consultation is the appropriate next step for understanding personalized planning and investment scope based on individual anatomy and goals.
Frequently Asked Questions About Penile Filler Before and After Erect
Will the filler be visible or palpable during erection? Properly placed sub-Dartos/Buck’s fascial plane filler integrates with tissue and expands proportionally. It is not visible as a distinct layer during erection.
Does filler increase erect length as well as girth? No. Filler placed outside the tunica albuginea increases girth in both states but does not increase erect length, which is governed by the tunica albuginea.
How soon will erect-state results be visible? Immediate enhancement is visible, but the true erect-state result stabilizes at 6 to 8 weeks as HA integrates with tissue.
What if the erect-state result does not look proportional? HA is reversible with hyaluronidase, and the staged protocol allows proportionality to be assessed and corrected at follow-up.
Will a partner notice the difference during intercourse? Partners commonly notice improvement during intercourse. The 2025 Cureus case report documented a natural feel and appearance at six months.
Is there any risk to erection quality or sensation? Retrospective data on nearly 500 patients reported no cases of erectile dysfunction or penile sensation loss with properly performed HA procedures.
Conclusion: The Erect State Is the Only Benchmark That Matters, and It Can Be Engineered
The erect state is the only clinically and psychologically meaningful benchmark for evaluating penile filler outcomes, yet virtually no competitor content addresses it with the anatomical depth or clinical evidence it deserves.
The biomechanical reason is clear: sub-Dartos/Buck’s fascial plane placement outside the tunica albuginea allows filler to expand proportionally during erection, producing natural results by design. The differentiators of 15,000-plus procedures, a staged treatment philosophy, and anatomical precision are not marketing claims; they are the specific clinical reasons erect-state aesthetics remain consistently natural and proportional.
The research gap remains: most clinical studies and competitor galleries document only flaccid results. The erect-state outcome is the question the industry has largely left unanswered, and Stoller Medical Group’s approach is built around answering it. For the successful man who has been quietly researching this topic, the answer is now clear. The procedure works in the erect state, the mechanism is understood, the safety data is robust, and one of the most experienced providers in the country is available for a free consultation.
Ready to See What Your Results Could Look Like? Schedule Your Free Consultation
Men ready to move from research to answers can schedule a free consultation at any of Stoller Medical Group’s five locations: Manhattan, Long Island, Albany, Pennsylvania, and Minnesota.
The consultation is a clinical conversation about anatomy, goals, and staged treatment planning, not a sales appointment. It is where erect-state goals are discussed specifically, so patients can ask direct questions and receive individualized answers based on their own anatomy.
The reassurances are concrete: a free consultation, reversible HA filler, a staged protocol, 15,000-plus procedures performed, and no reported cases of erectile dysfunction or sensation loss. Discretion is prioritized at every stage of the patient experience.
The next step is straightforward: book a free consultation today and receive a personalized treatment plan designed around erect-state goals.
